New nanocarrier drug delivery technology crosses the blood-brain barrier
Friday, April 17, 2020 - 09:40
in Biology & Nature
A Japanese research team has developed a cyclic peptide (a chain of amino acids bonded circularly) that enhances blood-brain barrier (BBB) penetration. By attaching the cyclic peptide to the surface of nanoparticles, research and development of new drug nanocarriers for drug delivery to the brain becomes possible.